2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis
Executive Summary
The 2020 World Society of Emergency Surgery (WSES) guidelines provide an updated, evidence-based framework for managing acute calculus cholecystitis (ACC). The central takeaway is the reinforced pivotal role of Early Laparoscopic Cholecystectomy (ELC) as the standard of care for the vast majority of patients. This recommendation now extends explicitly to "fragile" subgroups—including the elderly (over 80 years), patients with Child’s A and B cirrhosis, and pregnant patients—who were previously considered at high surgical risk.
Key updates include a decreased reliance on gallbladder drainage following the results of the CHOCOLATE trial, which demonstrated that surgery is superior to percutaneous drainage even in high-risk patients. Diagnostic protocols emphasize a combination of clinical, laboratory, and imaging findings, as no single feature is sufficiently definitive. For difficult surgical cases, subtotal cholecystectomy is recognized as a safe and effective alternative to total removal or conversion to open surgery.
1. Diagnostic Framework for ACC
The diagnosis of ACC should never rely on a single clinical or laboratory finding. Instead, a multimodal approach is required.
1.1 Clinical and Laboratory Indicators
Clinical Presentation: Essential features include a detailed history of right upper quadrant pain or tenderness, fever, vomiting, and food intolerance. Murphy’s sign remains a traditional but not exclusively definitive physical finding (Positive Likelihood Ratio 2.8).
Laboratory Tests: Elevated C-reactive protein (CRP) and white blood cell (WBC) counts are primary inflammatory markers.
Reliability: The Tokyo Guidelines (TG13) criteria for diagnosis showed limited reliability in some studies, with one cross-sectional analysis reporting an accuracy of only 60.3%.
1.2 Imaging Modalities
Abdominal Ultrasound (US): The recommended first-line imaging technique due to cost-effectiveness, lack of radiation, and wide availability. While summary sensitivity is 81% and specificity 83%, it is highly operator-dependent.
HIDA Scan: Provides the highest sensitivity and specificity for ACC compared to all other modalities, though its use is limited by resource and time requirements.
Magnetic Resonance Imaging (MRI): Found to be as accurate as abdominal US.
Computed Tomography (CT): Generally considered to have poor diagnostic accuracy for ACC specifically, though it may be useful in ruling out other conditions.
2. Management of Associated Common Bile Duct Stones (CBDS)
CBDS occurs in 10% to 20% of gallstone cases, but only 5% to 15% of ACC cases.
2.1 Risk Stratification
The WSES suggests a modified risk classification to guide the use of invasive diagnostics like ERCP:
2.2 Diagnostic and Therapeutic Tools
Liver Function Tests (LFTs): LFTs alone are insufficient to confirm CBDS. Gamma-glutamyl transpeptidase (GGT) is the most reliable LFT (Sensitivity 80.6% at a cut-off of 224 IU/L).
Second-Level Imaging: MRCP (Sensitivity 93%) and Endoscopic Ultrasound (EUS, Sensitivity 95%) are equivalent in accuracy and can reduce inappropriate ERCP procedures by 30-75%.
Intraoperative Options: Intraoperative Cholangiography (IOC) and Laparoscopic Ultrasound (LUS) are equivalent for detecting stones during surgery.
3. Surgical Treatment Strategies
Laparoscopic cholecystectomy is the first-line treatment. It should only be avoided in cases of septic shock or absolute anesthesia contraindications.
3.1 Fragile and High-Risk Subgroups
The Elderly (Over 80): ELC is strongly favored. Non-operative management is associated with readmission rates exceeding 50% and higher long-term mortality.
Cirrhosis: Safe for Child’s A and B patients. Laparoscopy reduces hospital stay and complications compared to open surgery in these patients. Child’s C remains controversial; surgery should be avoided unless conservative management fails.
Pregnancy: Cholecystectomy is recommended as first-line therapy to avoid relapse (10% rate) and potential drug toxicity to the fetus. The second trimester is the optimal time for intervention.
3.2 Managing the "Difficult Gallbladder"
When the "critical view of safety" cannot be obtained due to severe inflammation or adhesions, Subtotal Cholecystectomy is recommended. This approach avoids bile duct injury while achieving comparable morbidity rates to total cholecystectomy in difficult scenarios. Conversion to open surgery remains a valid "bailout" option in the event of severe bleeding or suspected ductal injury.
4. Optimal Timing of Intervention
Early Laparoscopic Cholecystectomy (ELC): Should be performed as soon as possible, ideally within 7 days of hospital admission and within 10 days of symptom onset.
Comparative Outcomes: ELC is superior to Intermediate (7 days to 6 weeks) and Delayed (after 6 weeks) cholecystectomy. ELC reduces total hospital stay by approximately 4 days and allows for an earlier return to work (by ~9 days) compared to delayed approaches.
5. Alternative and Non-Operative Management
5.1 Non-Operative Management (NOM)
NOM (antibiotics and observation) is reserved for patients who refuse surgery or are physiologically unsuitable. It carries a 30% risk of recurrent gallstone-related complications.
5.2 Gallbladder Drainage
The role of drainage has been downgraded based on the CHOCOLATE trial, which proved ELC is superior to Percutaneous Transhepatic Gallbladder Drainage (PTGBD) in high-risk patients (5% vs 53% major complication rate). Drainage is now recommended only for:
Patients fundamentally unsuitable for surgery.
Patients failing NOM who are still unfit for surgery.
5.3 Advanced Endoscopic Techniques
In patients unsuitable for surgery, EUS-guided transmural gallbladder drainage (EUS-GBD) using Lumen-apposing self-expandable metal stents (LAMS) is a safe and effective alternative to percutaneous drainage. It offers the advantage of internalizing bile and reducing post-procedural pain.
6. Antibiotic Stewardship
6.1 Uncomplicated vs. Complicated ACC
Uncomplicated ACC: Routine postoperative antibiotics are not recommended once the gallbladder is removed.
Complicated ACC: Antimicrobial regimens should target Gram-negative aerobes (E. coli, Klebsiella) and anaerobes (B. fragilis).
6.2 Biliary Penetration of Antibiotics
Antibiotic selection should consider the efficiency of the drug's penetration into the bile:
7. Conclusions and Research Directions
The WSES guidelines advocate for a "culture of safety" in laparoscopic cholecystectomy. Future research priorities include:
Improving prognostic models for shared decision-making.
Standardizing the definition of "high-risk" patients.
Developing a common language for classifying "difficult operative scenarios" to improve the quality of future surgical studies.
